Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia

INTRODUCTION: Gout affects 2.5% of the UK's adult population and is now the most common type of inflammatory arthritis. The long-term management of gout requires reduction of serum urate levels and this is most often achieved with use of xanthine oxidase inhibitors, such as allopurinol. Febuxos...

Descripción completa

Detalles Bibliográficos
Autores principales: MacDonald, Thomas M, Ford, Ian, Nuki, George, Mackenzie, Isla S, De Caterina, Raffaele, Findlay, Evelyn, Hallas, Jesper, Hawkey, Christopher J, Ralston, Stuart, Walters, Matthew, Webster, John, McMurray, John, Perez Ruiz, Fernando, Jennings, Claudine G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Research Methods
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120410/
https://www.ncbi.nlm.nih.gov/pubmed/25011991
http://dx.doi.org/10.1136/bmjopen-2014-005354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120410/
https://www.ncbi.nlm.nih.gov/pubmed/25011991
http://dx.doi.org/10.1136/bmjopen-2014-005354

Ejemplares similares